Wealthspire Advisors (Maryland)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | $1.68M | Buy |
2,993
+2,124
| +244% | +$1.19M | 0.06% | 145 |
|
|
2020
Q2 | $542K | Buy |
869
+206
| +31% | +$128K | 0.04% | 242 |
|
|
2020
Q1 | $324K | Sell |
663
-318
| -32% | -$155K | 0.03% | 292 |
|
|
2019
Q4 | $368K | Buy |
981
+100
| +11% | +$37.5K | 0.02% | 327 |
|
|
2019
Q3 | $244K | Buy |
881
+39
| +5% | +$10.8K | 0.02% | 390 |
|
|
2019
Q2 | $264K | Sell |
842
-564
| -40% | -$177K | 0.02% | 379 |
|
|
2019
Q1 | $577K | Buy |
1,406
+865
| +160% | +$355K | 0.04% | 229 |
|
|
2018
Q4 | $202K | Buy |
541
+83
| +18% | +$31K | 0.02% | 398 |
|
|
2018
Q3 | $185K | Buy |
458
+16
| +4% | +$6.46K | 0.02% | 482 |
|
|
2018
Q2 | $152K | Sell |
442
-27
| -6% | -$9.29K | 0.01% | 551 |
|
|
2018
Q1 | $162K | Sell |
469
-349
| -43% | -$121K | 0.02% | 534 |
|
|
2017
Q4 | $308K | Buy |
818
+46
| +6% | +$17.3K | 0.03% | 363 |
|
|
2017
Q3 | $345K | Buy |
772
+306
| +66% | +$137K | 0.04% | 327 |
|
|
2017
Q2 | $229K | Buy |
466
+371
| +391% | +$182K | 0.03% | 409 |
|
|
2017
Q1 | $37K | Sell |
95
-30
| -24% | -$11.7K | 0.01% | 888 |
|
|
2016
Q4 | $46K | Buy |
125
+72
| +136% | +$26.5K | 0.01% | 790 |
|
|
2016
Q3 | $21K | Buy |
53
+16
| +43% | +$6.34K | ﹤0.01% | 1039 |
|
|
2016
Q2 | $13K | Sell |
37
-17
| -31% | -$5.97K | ﹤0.01% | 1138 |
|
|
2016
Q1 | $19K | Sell |
54
-16
| -23% | -$5.63K | ﹤0.01% | 990 |
|
|
2015
Q4 | $38K | Buy |
+70
| New | +$38K | 0.01% | 792 |
|